Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: Focus on davunetide (NAP)

Iddo Magen, Illana Gozes

Research output: Contribution to journalReview articlepeer-review

Abstract

This review focuses on the therapeutic effects and mechanisms of action of NAP (davunetide), an eight amino acid snippet derived from activity-dependent neuroprotective protein (ADNP) which was discovered in our laboratory. We have recently described the effects of NAP in neurodegenerative disorders, and we now review the beneficial effects of NAP and other microtubule-stabilizing agents on impairments in axonal transport. Experiments in animal models of microtubule-deficiency including tauopathy (spanning from drosophila to mammals) showed protection of axonal transport by microtubule-stabilizers and NAP, which was coupled to motor and cognitive protection. Clinical trials with NAP (davunetide) are reviewed paving the path to future developments.

Original languageEnglish
Pages (from-to)489-495
Number of pages7
JournalNeuropeptides
Volume47
Issue number6
DOIs
StatePublished - Dec 2013

Keywords

  • Activity-dependent neuroprotective protein (ADNP)
  • Axonal transport
  • Davunetide
  • NAP
  • Neurodegenerative diseases
  • Neurological disorders

Fingerprint

Dive into the research topics of 'Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: Focus on davunetide (NAP)'. Together they form a unique fingerprint.

Cite this